NCT05066412View on ClinicalTrials.gov

Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 26, 2024

Primary Completion Date

June 2, 2026

Study Completion Date

December 2, 2026

Conditions
Hematologic MalignancyHaplo-identical Stem Cell Transplantation
Interventions
OTHER

CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology

CD45RAneg cells, prepared from mononuclear cell leukapheresis by CliniMACS® technology

Trial Locations (1)

1205

RECRUITING

HUG, Geneva

All Listed Sponsors
lead

University Hospital, Geneva

OTHER